References
- Berg K. A new serum type system in man—the Lp system. Acta Pathol Microbiol Scand 1963; 59: 369–82
- McLean J W, Tomlinson J E, Kuang W-J, et al. cDNA sequenee of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 300: 132–7
- Utermann G, Kraft H G, Menzel H J, Hopferwieser T, Seitz C. Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of Lp(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Hum Genet 1988; 78: 41–6
- Utermann G, Duha C, Menzel H J. Genetics of the quantitative Lp(a) lipoprotein trait. II. Inheritance of Lp(a) glycoprotein phenotypes. Hum Genet 1988; 78: 47–50
- Dahlén G H, Guyton J R, Attar M, Farmer J A, Kautz J A, Gotto A M. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758–65
- Rhoads G, Dahl G., Én G H, Berg K, Morton N E, Dannenherg A L. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc 1986; 256: 2540–4
- Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1989; 78: 145–50
- Takegoshi T, Haba T, Hirai J, Kitoh C, Saga T, Yamazaki Y, Mabuchi H. Alterations of lipoprotein(a) in patients with diabetic nephropathy (letter). Atherosclerosis 1990; 83: 99–100
- Wright L C, Sullivan D R, Muller M, Dyne M, Tattersall M HN, Mountford C E. Elevated apolipoprotein(a) levels in cancer patients. Int J Cancer 1989; 43: 241–4
- Bruckert E, Davidoff P, Grimaldi A, Truffert J, Giral P, Doumith R, Thervet F, De Gennes J L. Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control (letter). J Am Med Assoc 1990; 263: 35–6
- Ehnholm C, Garoff H, Renkonen O, Simons K. Protein and carbohydrate composition of Lp(a) lipoprotein from human plasma. Biochemistry 1972; 11: 3229–32
- Siegler L, Wu W T. Separation of serum high-density lipoprotein for cholesterol determination: ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride. Clin Chem 1981; 27: 838–41
- Dahlén G H. Incidence of Lp(a) lipoprotein among populations. Lipoprotein(a), A M Scanu. Academic Press, San Diego 1990; 151–73
- Wilkinson L. SYSTAT: The System for Statistics. SYSTAT, Evanston, IL 1989
- McNamara J R, Campos H, Adolphson J L, et al. Screening for lipoprotein(a) elevations in plasma and assessment of size heterogeneity using gradient gel electrophoresis. J Lipid Res 1989; 30: 747–55
- Stubbe I, Gustafson A, Nilsson-Ehle P. Alterations in plasma proteins and lipoproteins in acute myocardial infarction: effects on activation of lipoprotein lipase. Scan J Clin Lab Invest 1982; 42: 437–44
- Hajjar K A, Gavish D, Breslow J L, Nachman R L. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339: 303–5
- Loscalzo J, Weinfeld M, Fless G M, Scanu A M. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990; 10: 240–5
- Johansson B G, Kindmark C-O, Trell E Y, Wollheim F A. Sequential changes of plasma proteins after myocardial infarction. Scand J Clin Lab Invest 1972; 29(Suppl. 124)117–26